List of Excipients in API denosumab-bmwo
✉ Email this page to a colleague
Detailed excipient profiles for denosumab-bmwo
Excipient focus: ACETIC ACID
denosumab-bmwo drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| CELLTRION USA Inc | denosumab-bmwo | 72606-037 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-038 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-058 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-059 |
| >Company | >Ingredient | >NDC |
denosumab-bmwo drug variants not containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
denosumab-bmwo drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| CELLTRION USA Inc | denosumab-bmwo | 72606-037 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-038 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-058 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-059 |
| >Company | >Ingredient | >NDC |
denosumab-bmwo drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
denosumab-bmwo drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| CELLTRION USA Inc | denosumab-bmwo | 72606-037 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-038 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-058 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-059 |
| >Company | >Ingredient | >NDC |
denosumab-bmwo drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
denosumab-bmwo drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| CELLTRION USA Inc | denosumab-bmwo | 72606-037 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-038 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-058 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-059 |
| >Company | >Ingredient | >NDC |
denosumab-bmwo drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
denosumab-bmwo drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| CELLTRION USA Inc | denosumab-bmwo | 72606-037 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-038 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-058 |
| CELLTRION USA Inc | denosumab-bmwo | 72606-059 |
| >Company | >Ingredient | >NDC |
denosumab-bmwo drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
